M Ouchi1, S Kinoshita2. 1. 1] Ouchi Eye Clinic, Kyoto, Japan [2] Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. 2. Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Abstract
PURPOSE: To evaluate the postoperative outcomes of cataract eyes complicated with coexisting ocular pathologies that underwent implantation of a refractive multifocal intraocular lens (MIOL) with a surface-embedded near section. METHODS: LENTIS MPlus (Oculentis GmbH) refractive MIOLs were implanted in 15 eyes with ocular pathologies other than cataract (ie, six high-myopia eyes with an axial length longer than 28 mm, two fundus albipunctatus eyes, two branch retinal-vein occlusion eyes, four glaucoma eyes (one with high myopia), and two keratoconus eyes). Uncorrected or corrected distance and near visual acuity (VA) (UDVA, UNVA, CDVA, and CNVA), contrast sensitivity, and defocus curve were measured at 1 day and 6 months postoperatively, and each patient completed a 6-month postoperative questionnaire regarding vision quality and eyeglass use. RESULTS: Thirteen eyes (87%) registered 0 or better in CDVA and 12 eyes (73%) registered better than 0 in CNVA. Contrast sensitivity in the eyes of all patients was comparable to that of normal healthy subjects. No patient required eyeglasses for distance vision, but three patients (20%) required them for near vision. No patient reported poor or very poor vision quality. CONCLUSION: With careful case selection, sectorial refractive MIOL implantation is effective for treating cataract eyes complicated with ocular pathologies.
PURPOSE: To evaluate the postoperative outcomes of cataract eyes complicated with coexisting ocular pathologies that underwent implantation of a refractive multifocal intraocular lens (MIOL) with a surface-embedded near section. METHODS: LENTIS MPlus (Oculentis GmbH) refractive MIOLs were implanted in 15 eyes with ocular pathologies other than cataract (ie, six high-myopia eyes with an axial length longer than 28 mm, two fundus albipunctatus eyes, two branch retinal-vein occlusion eyes, four glaucoma eyes (one with high myopia), and two keratoconus eyes). Uncorrected or corrected distance and near visual acuity (VA) (UDVA, UNVA, CDVA, and CNVA), contrast sensitivity, and defocus curve were measured at 1 day and 6 months postoperatively, and each patient completed a 6-month postoperative questionnaire regarding vision quality and eyeglass use. RESULTS: Thirteen eyes (87%) registered 0 or better in CDVA and 12 eyes (73%) registered better than 0 in CNVA. Contrast sensitivity in the eyes of all patients was comparable to that of normal healthy subjects. No patient required eyeglasses for distance vision, but three patients (20%) required them for near vision. No patient reported poor or very poor vision quality. CONCLUSION: With careful case selection, sectorial refractive MIOL implantation is effective for treating cataract eyes complicated with ocular pathologies.
Authors: José M Artigas; José L Menezo; Cristina Peris; Adelina Felipe; Manuel Díaz-Llopis Journal: J Cataract Refract Surg Date: 2007-12 Impact factor: 3.351
Authors: Jay S Pepose; Mujtaba A Qazi; James Davies; John F Doane; James C Loden; Varunan Sivalingham; Ashraf M Mahmoud Journal: Am J Ophthalmol Date: 2007-07-25 Impact factor: 5.258
Authors: Jorge L Alió; David P Piñero; Ana B Plaza-Puche; Maria Joanna Rodriguez Chan Journal: J Cataract Refract Surg Date: 2011-02 Impact factor: 3.351
Authors: Jorge L Alio; Ana B Plaza-Puche; Jaime Javaloy; María José Ayala; Luis J Moreno; David P Piñero Journal: Ophthalmology Date: 2012-01-03 Impact factor: 12.079
Authors: S Pieh; B Lackner; G Hanselmayer; R Zöhrer; M Sticker; H Weghaupt; A Fercher; C Skorpik Journal: Br J Ophthalmol Date: 2001-07 Impact factor: 4.638
Authors: Rosa Braga-Mele; David Chang; Steven Dewey; Gary Foster; Bonnie An Henderson; Warren Hill; Richard Hoffman; Brian Little; Nick Mamalis; Thomas Oetting; Donald Serafano; Audrey Talley-Rostov; Abhay Vasavada; Sonia Yoo Journal: J Cataract Refract Surg Date: 2014-02 Impact factor: 3.351
Authors: C Lisa; R Zaldivar; A Fernández-Vega Cueto; R M Sanchez-Avila; D Madrid-Costa; J F Alfonso Journal: J Ophthalmol Date: 2018-04-19 Impact factor: 1.909